API Innovation Center

We’re excited to announce that the API Innovation Center is joining Securing America's Medicines and Supply’s growing coalition of companies advocating for policy recommendations to address ongoing chronic drug shortages. This collaboration allows for the API Innovation Center to share our perspective and experience in enabling the delivery of U.S.-made active pharmaceutical ingredients. Our Chair and Founder, Anthony Sardella, adds, “We are proud to join SAMS and its members in strengthening the availability of high-quality, generic medications for patients, healthcare systems, and pharmacies. We look forward to informing key stakeholders on the critical issues related to reshoring essential medications to build our nation’s health security.” Read the full announcement on our website: https://lnkd.in/eQK9nwYz #API #STL #Pharma #Innovation #AdvancedManufacturing #Missouri 

“I’m really sorry,” Sarah Louise Butler said, “I don’t normally cry about my health issues. But this is breaking me.”     A new article from Science Friday reveals the pain patients are grappling with while seeking necessary treatments amidst ever-present #drugshortages. Read the article here: https://lnkd.in/eszn8fwV    At the API Innovation Center, we are at the forefront of efforts to ensure that these patients have access to critical drugs through supply chain efficiency and by leveraging advanced manufacturing technologies.     Check out our Bold Goals White Paper for more information on how our efforts are shaping the future of the pharmaceutical industry and to view immediate, short, and long-term actions necessary to return API production to the U.S.: https://lnkd.in/e4hU8Xpy #supplychain #API #reshoring

We are thrilled to announce the Advanced Pharmaceutical Manufacturing Technology Conference, hosted by the API Innovation Center in collaboration with the Missouri Chamber of Commerce and Industry, on August 28th, 2024, in St. Louis! This event will showcase the latest advancements in Advanced Manufacturing Technologies (AMT) by bringing key instrument and equipment vendors together with industry practitioners. Event Highlights: 🔷Cutting-edge Presentations: Learn from industry leaders about the latest innovations in AMT and the pharmaceutical industry. 🔷Survey Insights: Discover the results of our comprehensive survey on AMT adoption in pharmaceutical manufacturing, with insights to be further explored at our 2nd Annual Plenary Event on November 13th, 2024. 🔷Networking Opportunities: Connect with peers, industry experts, and key stakeholders. Last year, our inaugural plenary event focused on the bold goal of reshoring 25% of small molecule API to the U.S. within five years. This year's conference will continue this critical conversation, delving deeper into the role of AMTs in achieving these goals and exploring the challenges and solutions in implementing these technologies. Don't miss this opportunity to engage with experts, discover innovative technologies, and be part of a crucial dialogue that will help shape the future of pharmaceutical manufacturing. Save the Date: August 28th, 2024 Location: St. Louis, MO RSVP: https://lnkd.in/gtDk8X8b Stay tuned for more details! We look forward to seeing you there. 👥💡 #PharmaceuticalManufacturing #AdvancedManufacturing #TechnologyConference #APIInnovationCenter #AMT #IndustryInnovation #Networking #PharmaTech

Thank you to everyone who joined us for our event on Wednesday! We had a great lineup of speakers to discuss policy solutions to drug shortages. The federal government is prioritizing this policy issue through cross-cutting Department of Health and Human Services collaborations, and speakers noted the promise of recently proposed demand-side reforms to prevent drug shortages—though, some work remains to ensure the reforms have their intended effect. Panelists also highlighted the need for holistic supply chain assessments that can be used to inform purchasing decisions, along with a need for supply-side investments to enable manufacturing infrastructure upgrades and adoption of advanced manufacturing technologies. If you missed the event or would like to review the content, a recording and slide deck are available here: https://duke.is/c/sasg (One additional speaker is not pictured below: Meena Seshamani)

Yesterday, Gerren McHam from the API Innovation Center participated in a panel discussion on implementing policy to prevent drug shortages, building on our collaborative work with the Duke-Margolis ReVAMP Drug Supply Chain Consortium. This event brought together consortium members and industry leaders in discussions on increasing supply chain reliability and reducing the frequency and severity of drug shortages. The panel, “Enabling Reliability through Advanced Manufacturing Technologies,” included Mark Godfrey from Eli Lilly and Company, Andrew J. Carpenter, Ph.D., from Phlow, and Joel Welch from the U.S. Food and Drug Administration (FDA), and was moderated by Gerrit Hamre from the Duke-Margolis Institute for Health Policy. They discussed existing federal programs that can drive increased adoption of advanced manufacturing technologies (AMTs) and opportunities for leveraging AMTs for improvements in reliability, quality assurance, and national health security. During the panel, we shared our success story of developing Lomustine API with AMTs and how we will continue to invest in advanced technologies to drive reliability in the supply chain. We're committed to advancing these initiatives to ensure a more reliable and secure pharmaceutical supply chain for all. Thank you to Betsy Baer, US Pharmacopeia, for these photos! #AdvancedManufacturingTechnologies #SupplyChainResilience

Drug shortages and supply chain issues continue to threaten patients in need of life-saving treatments. This Wednesday, June 12, the Duke-Margolis Institute for Health Policy will host an event to discuss potential policy solutions needed to address these challenges. This hybrid meeting will build off the existing work of the Duke-Margolis ReVAMP Drug Supply Chain Consortium, which aims to increase supply chain reliability and reduce the frequency and severity of drug shortages. Learn more about the event and register here: https://duke.is/c/sasg

A new report from US Pharmacopeia analyzes the factors fueling our nation’s drug shortage crisis using data and insights from the USP Medicine Supply Map. Drug shortages are now lasting longer than ever, with the average duration for a drug to be on a shortage list increasing from 2 years in 2020 to over 3 years in 2023. The report delves into the economic factors contributing to these persistent shortages, underscoring the complexity of the issue. Addressing these challenges will require a concerted effort from all stakeholders to ensure patients have consistent access to the medications they need. Read the full report from US Pharmacopeia and learn more about the factors driving this crisis: https://ow.ly/PPWS50S7Nit #DrugShortage #SupplyChain

Insights from our COO, Kevin Webb, were recently featured in Pharma Manufacturing's latest cover story on reshoring pharmaceutical manufacturing in the United States. This two-part series explores domestic manufacturing efforts and highlights the challenges, opportunities, and the critical role of government support in reshoring critical medicines. Read the introduction here: https://lnkd.in/gK_4UM3Z Read Part 1-Targeting government spending here: https://lnkd.in/ggpkaTfq Read Part 2- Sustaining efforts once infrastructure investments dry up here: https://lnkd.in/gz39wdST #reshoring #domesticmanufacturing #supplychain #pharmamanufacturing #innovation

The government’s investments into generic drugs and APIs have created an air of excitement surrounding the westward migration of manufacturing. Now comes arguably the most vital phase of U.S. domestic manufacturing efforts — figuring out where to get the most lasting bang for our reshoring bucks. With the pandemic finally in our rearview, the U.S. has what many industry insiders see as a golden opportunity to candidly assess pharma’s reshoring progress — and create a more formal plan for supply chain resilience. Read the intro here: https://lnkd.in/gK_4UM3Z Part 1 here: https://lnkd.in/ggpkaTfq Part 2 here: https://lnkd.in/gz39wdST #reshoring #domesticmanufacturing #BARDA #ASPR #pharmamanufacturing Marta E. Wosinska, Ph.D., Bikash Chatterjee, Eric Edwards, MD, PhD, Salvatore Mascia, Kevin Webb, Phlow, CONTINUUS Pharmaceuticals

Manufacturers, we need your voice!   The API Innovation Center is proud to be working with the Missouri Chamber of Commerce and Industry on a strategic plan to increase our state’s manufacturing competitiveness. Join them in St. Louis, Kansas City, Springfield, or Jeff City for an early look at the findings, and make sure your ideas are part of the final plan.   Register for a FREE roundtable near you: https://lnkd.in/gEFxrXG3 #Missouri #STL #Manufacturing